Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia

Heart Rhythm

Volumn 8, Issue 6, 2011, Pages 864-871

  Sy, Raymond W ^a   Gollob, Michael H ^b   Klein, George J ^a   Yee, Raymond ^a   Skanes, Allan C ^a   Gula, Lorne J ^a   Leong Sit, Peter ^a   Gow, Robert M ^b   Green, Martin S ^b   Birnie, David H ^b   Krahn, Andrew D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Catecholamines; Electrocardiogram; Genetics; Sudden death; Ventricular tachycardia

Indexed keywords

RYANODINE RECEPTOR 2;

ADOLESCENT; ADRENALIN RELEASE; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; AUTOMATIC CARDIOVERSION; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; EXERCISE; FATALITY; FEMALE; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; QRS COMPLEX; RECURRENT DISEASE; SCHOOL CHILD; SCREENING TEST; SUDDEN DEATH; SYNCOPE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DNA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; ONTARIO; RISK FACTORS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SURVIVAL RATE; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; YOUNG ADULT;

EID: 79957745736     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.01.048     Document Type: Article

References (28)

1. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 1978;40 suppl:28-37.
2. Katz G, Arad M, Eldar M. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Curr Probl Cardiol 2009;34:9-43.
3. Lehnart SE, Wehrens XH, Laitinen PJ, et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 2004;109:3208-3214.
4. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-490. (Pubitemid 32116230)
5. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. (Pubitemid 34747444)
6. Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-2434.
7. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-1519.
8. di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006;114:1012-1019. (Pubitemid 44358877)
9. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine-or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-2827. (Pubitemid 32550071)
10. Cerrone M, Noujaim SF, Tolkacheva EG, et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2007;101:1039-1048. (Pubitemid 350084981)
11. Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 2006;113:1385-1392. (Pubitemid 43739434)
12. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol 2009;54:2065-2074.
13. Bauce B, Rampazzo A, Basso C, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002;40:341-349. (Pubitemid 34756298)
14. Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42:863-870. (Pubitemid 41598196)
15. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007;4:675-678. (Pubitemid 46655581)
16. Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008;358:2024-2029. (Pubitemid 351656456)
17. Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol 2005;16:162-166. (Pubitemid 40326272)
18. Watanabe H, Chopra N, Laver D, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-383.
19. Haugaa KH, Leren IS, Berge KE, et al. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutationpositive family members diagnosed by cascade genetic screening. Europace 2010;12:417-423.
20. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003;89:66-70. (Pubitemid 36044293)
21. Leenhardt A, Glaser E, Burguera M, Nurnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994;89:206-215.
22. Priori SG, Napolitano C. Intracellular calcium handling dysfunction and arrhythmogenesis: a new challenge for the electrophysiologist. Circ Res 2005;97:1077-1079.
23. Kang G, Giovannone SF, Liu N, et al. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy. Circ Res 2010;107:512-519.
24. Fisher JD, Krikler D, Hallidie-Smith KA. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol 1999;34:2015-2022.
25. Sumitomo N, Sakurada H, Taniguchi K, et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007;71:1606-1609. (Pubitemid 47529664)
26. Bhuiyan ZA, van den Berg MP, van Tintelen JP, et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 2007;116:1569-1576.
27. Wongcharoen W, Chen YC, Chen YJ, et al. Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm 2007;4:1338-1349. (Pubitemid 47495729)
28. Vest JA, Wehrens XH, Reiken SR, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-2032. (Pubitemid 40577896)